Intravenous single dose of tranexamic acid safely reduces blood loss and the need for transfusion in elderly patients with hip fracture. A randomized double-blinded controlled trial at 1-year follow-up

• 主要な著者: Francisco A Miralles-Muñoz (著者), Rosario Martin-Grandes (著者), Daniel Martinez-Mendez (著者), Gerard Mahiques-Segura (著者), Alejandro Lizaur-Utrilla (著者), María Flores Vizcaya-Moreno (著者)
• フォーマット: 図書
• 出版事項: Annals of Musculoskeletal Medicine - Peertechz Publications, 2023-11-21.
• 主題: Research Article
• オンライン･アクセス: Connect to this object online.

<p>Background: A hip fracture usually presents significant blood loss in the perioperative period, with a transfusion rate of 20-60%. In order to reduce the complications associated with this procedure, the administration of Tranexamic Acid (TXA) has been implemented in the treatment of periop...